Smoking cessation in clinical practice: predictors of six-month continuous abstinence in a sample of Greek smokers

Boutou, Afroditi; Tsiata, Eleni A; Pataka, Athanasia; Kontou, Paschalina; Pitsiou, Georgia; Argyropoulou, Paraskevi

doi:10.3132/pcrj.2008.00009

Cited by 36 publications

(36 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We avoided this by using a validated measure involving ratings of current urges to smoke and adjust statistically for whether this was during normal smoking or a period of abstinence [32]. However, our findings with regard to medication are consistent with many prospective real-world studies [18,21,25,[35][36][37][38].…”

Section: Discussionsupporting

confidence: 80%

‘Real-world’ effectiveness of smoking cessation treatments: a population study

2013

View full text Add to dashboard Cite

After adjusting for major confounding variables such as tobacco dependence, smokers in England who use a combination of behavioural support and pharmacotherapy in their quit attempts have almost three times the odds of success than those who use neither pharmacotherapy nor behavioural support. Smokers who buy nicotine replacement therapy over the counter with no behavioural support have similar odds of success in stopping as those who stop without any aid.

show abstract

Section: Discussionsupporting

confidence: 80%

‘Real-world’ effectiveness of smoking cessation treatments: a population study

2013

View full text Add to dashboard Cite

show abstract

“…Pharmacotherapy did not have a significant effect on success in our study. Although the study design of Boutou et al 41 was prospective, in our opinion, it would be improper to draw a conclusion from the longterm results, since the follow-up time was only 6 months.…”

Section: Discussionmentioning

confidence: 99%

“…Also, the use of bupropion and smoking the first cigarette of the day 30 min after getting up has been shown to increase quitting success. 41 Since our study was not a prospective one, we could only analyze the variables that had been recorded, and nicotine withdrawal symptoms could not be analyzed in our study. As it is observed, sleep disorders should be examined from both perspectives.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Relapse Rate and Factors Related to Relapse in a 1-Year Follow-Up of Subjects Participating in a Smoking Cessation Program

et al. 2015

View full text Add to dashboard Cite

BACKGROUND:The most important and difficult task when it comes to reducing tobacco-related morbidity and mortality is to convince smokers to quit and to maintain their abstinence. This study aimed to determine the smoking relapse rate and factors related to relapse in subjects who participated in a smoking cessation program and completed a 1-y follow-up in our center. METHODS: The study included 550 subjects who applied to a smoking cessation clinic from June 1, 2011 to December 31, 2011 and completed the 1-y follow-up. RESULTS: After 1 y, 282 (51.4%) subjects had relapsed, 132 (24%) had quit smoking, and 135 (24.6%) could not be contacted. The mean age ؎ SD was 41.5 ؎ 10.8 y, and 52.5% were male. There was no difference between non-relapsed and relapsed subjects with regard to age, sex, average smoking duration and daily number of cigarettes, reason to quit, education level, presence of symptoms and concomitant diseases, Fagerström nicotine dependence score, Beck depression score, and frequency of pharmacotherapy administration. In the relapsed group, the age began smoking was younger (P ‫؍‬ .05), and the longest prior duration of abstinence was shorter (P ‫؍‬ .04). The average number of support contacts was found to be significantly higher in the non-relapsed subjects (P < .001). Logistic regression analysis revealed alcohol intake to be a factor influencing relapse (odds ratio: 2.11, 95% CI: 1.13-3.93, P ‫؍‬ .02), as was the number of support contacts (odds ratio: 2.06, 95% CI: 1.59 -2.65, P < .001). The presence of drug adverse effects was close to being significant (odds ratio: 1.96, 95% CI: 0.93-4.10, P ‫؍‬ .07). CONCLUSION: The relapse rate in a 1-y period was 51.4%. Similar to previous studies, alcohol intake presented a relapse risk. In subjects receiving drug treatment, planning support meetings more frequently and paying attention to adverse effects may increase the success of smoking cessation.

show abstract

“…6 He discusses the three main areas to be covered in one's discussions with the patient and their family: the likely disease course and survival prognosis; advance health care directives; and symptom management. Greek smokers, 7 reports that the time to first cigarette after waking, and use of bupropion, independently predict abstinence from cigarettes for a six-month period, whereas night awakening is negatively associated with abstinence.…”

mentioning

confidence: 99%